Title![]() |
Intervention | NCT ID | Sponsor | Status |
---|---|---|---|---|
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... | Exemestane, Laboratory Biomarker Analysis, Pharmacokinetic Study, Questionnaire Administration | NCT03300557 | National Cancer Institute (NCI) | Active, not recruiting |
Iloprost in Preventing Lung Cancer in Former Smokers | Iloprost, Quality-of-Life Assessment, Questionnaire Administration, Placebo Administration | NCT02237183 | National Cancer Institute (NCI) | Active, not recruiting |
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion | Laboratory Biomarker Analysis, Metformin Hydrochloride | NCT02581137 | National Cancer Institute (NCI) | Active, not recruiting |
MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer | Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine | NCT03300817 | National Cancer Institute (NCI) | Active, not recruiting |
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer | Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim, Surgical Procedure | NCT02636582 | National Cancer Institute (NCI) | Active, not recruiting |
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery | Endoxifen Hydrochloride, Placebo Administration, Questionnaire Administration | NCT03317405 | National Cancer Institute (NCI) | Active, not recruiting |
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-... | Denosumab, Salpingo-Oophorectomy | NCT03382574 | National Cancer Institute (NCI) | Recruiting |
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients | Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine | NCT03036930 | National Cancer Institute (NCI) | Active, not recruiting |
PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer... | Laboratory Biomarker Analysis, Placebo Administration, Rilimogene Galvacirepvec | NCT02326805 | National Cancer Institute (NCI) | Active, not recruiting |
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... | Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine | NCT02568566 | National Cancer Institute (NCI) | Active, not recruiting |
Why I Joined a Clinical Trial
Living through my sister’s heroic battle with breast cancer and being a woman at high risk, I knew there had to be a better way than “watch and wait”. Prevention became my passion; BCPT my clinical trial to find answers to prevent this disease for my young nieces and all women. Together, through clinical trials, we can prevent breast cancer.